These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15943649)

  • 1. Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder.
    Pourmand D; Kavanagh DJ; Vaughan K
    Aust N Z J Psychiatry; 2005 Jun; 39(6):473-8. PubMed ID: 15943649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive validity of the Family Attitude Scale in people with psychosis.
    Kavanagh DJ; Pourmand D; White A; Robertson D; Halford K; Vaughan K
    Psychiatry Res; 2008 Sep; 160(3):356-63. PubMed ID: 18710783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people.
    Fraser S; Hides L; Philips L; Proctor D; Lubman DI
    Schizophr Res; 2012 Apr; 136(1-3):110-5. PubMed ID: 22321667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.
    Kavanagh DJ; Waghorn G; Jenner L; Chant DC; Carr V; Evans M; Hemnan H; Jablensky A; McGrath JJ
    Schizophr Res; 2004 Feb; 66(2-3):115-24. PubMed ID: 15061243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
    Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
    J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.
    Caton CL; Drake RE; Hasin DS; Dominguez B; Shrout PE; Samet S; Schanzer B
    Arch Gen Psychiatry; 2005 Feb; 62(2):137-45. PubMed ID: 15699290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; First MB; Samet S; Schanzer B
    Br J Psychiatry; 2007 Feb; 190():105-11. PubMed ID: 17267925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic stability four years after a first episode of psychosis.
    Whitty P; Clarke M; McTigue O; Browne S; Kamali M; Larkin C; O'Callaghan E
    Psychiatr Serv; 2005 Sep; 56(9):1084-8. PubMed ID: 16148321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-episode psychosis: diagnostic stability over one and two years.
    Haahr U; Friis S; Larsen TK; Melle I; Johannessen JO; Opjordsmoen S; Simonsen E; Rund BR; Vaglum P; McGlashan T
    Psychopathology; 2008; 41(5):322-9. PubMed ID: 18635935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed emotion and health outcomes among Mexican-Americans with schizophrenia and their caregiving relatives.
    Breitborde NJ; López SR; Kopelowicz A
    J Nerv Ment Dis; 2010 Feb; 198(2):105-9. PubMed ID: 20145484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up.
    McCleery A; Addington J; Addington D
    Schizophr Res; 2006 Dec; 88(1-3):187-91. PubMed ID: 16942863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.
    Mauri MC; Di Pace C; Reggiori A; Paletta S; Colasanti A
    Asian J Psychiatr; 2017 Oct; 29():117-122. PubMed ID: 29061407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Gee D; Crisp K; Pearce T; Newman B; Spiliotacopoulos D; Castle D; McGorry PD
    J Clin Psychiatry; 2009 Apr; 70(4):477-86. PubMed ID: 19323964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study.
    Kapfhammer HP; Reininghaus EZ; Fitz W; Lange P
    J Clin Psychiatry; 2014 Oct; 75(10):1096-104. PubMed ID: 25373118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance misuse at presentation to an early psychosis program.
    Van Mastrigt S; Addington J; Addington D
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
    Faridi K; Pawliuk N; King S; Joober R; Malla AK
    Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity in psychosis at first hospitalization.
    Strakowski SM; Tohen M; Stoll AL; Faedda GL; Mayer PV; Kolbrener ML; Goodwin DC
    Am J Psychiatry; 1993 May; 150(5):752-7. PubMed ID: 8480821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-V research agenda: substance abuse/psychosis comorbidity.
    Rounsaville BJ
    Schizophr Bull; 2007 Jul; 33(4):947-52. PubMed ID: 17556751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.